| scholarly article | Q13442814 |
| P50 | author | Helen L. Fillmore | Q58802785 |
| P2093 | author name string | William C Broaddus | |
| Joy L Ware | |||
| Shawn E Holt | |||
| Aaron J Clark | |||
| Archana Chidambaram | |||
| Mike Y Chen | |||
| Dana C Chan | |||
| P2860 | cites work | Regulation of the proto-oncogenes bcl-2 and c-myc by the Wilms' tumor suppressor gene WT1 | Q24313334 |
| WT1 suppresses synthesis of the epidermal growth factor receptor and induces apoptosis | Q24313596 | ||
| A novel repressor, par-4, modulates transcription and growth suppression functions of the Wilms' tumor suppressor WT1 | Q24324095 | ||
| Human platelet-derived growth factor A chain is transcriptionally repressed by the Wilms tumor suppressor WT1 | Q24337538 | ||
| WT1 interacts with the splicing factor U2AF65 in an isoform-dependent manner and can be incorporated into spliceosomes | Q24596062 | ||
| An alternative, nonapoptotic form of programmed cell death | Q24672152 | ||
| INO80 and gamma-H2AX interaction links ATP-dependent chromatin remodeling to DNA damage repair. | Q27933934 | ||
| 53BP1 and NFBD1/MDC1-Nbs1 function in parallel interacting pathways activating ataxia-telangiectasia mutated (ATM) in response to DNA damage | Q28236024 | ||
| Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus | Q28236741 | ||
| RNA editing in the Wilms' tumor susceptibility gene, WT1 | Q28238638 | ||
| WT-1 is required for early kidney development | Q28512266 | ||
| The Wilms' tumor gene product WT1 mediates the down-regulation of the rat epidermal growth factor receptor by nerve growth factor in PC12 cells | Q28576102 | ||
| Expression of the insulin-like growth factor I receptor C terminus as a myristylated protein leads to induction of apoptosis in tumor cells. | Q48544609 | ||
| Expression of the Wilms' tumor gene product WT1 in glioblastomas and medulloblastomas | Q49072671 | ||
| Physical interaction between Wilms tumor 1 and p73 proteins modulates their functions. | Q52169566 | ||
| Wilms' tumour gene 1 (WT1) in human neoplasia. | Q52938297 | ||
| Expression of the Wilms' tumor gene (WT1) in human leukemias | Q53490672 | ||
| Regulation of insulin-like growth factor I receptor gene expression by the Wilms' tumor suppressor WT1. | Q54372832 | ||
| Repression of the insulin-like growth factor II gene by the Wilms tumor suppressor WT1 | Q67493857 | ||
| Synergism of taxol and gallium nitrate in human breast carcinoma cells: schedule dependency | Q72699561 | ||
| Regulation of insulin-like growth factor I receptor promoter activity by wild-type and mutant versions of the WT1 tumor suppressor | Q73025306 | ||
| Induction of p21 by the Wilms' tumor suppressor gene WT1 | Q73235597 | ||
| Tyrosine kinase inhibitor emodin suppresses growth of HER-2/neu-overexpressing breast cancer cells in athymic mice and sensitizes these cells to the inhibitory effect of paclitaxel | Q74484391 | ||
| Transcriptional regulation by the Wilms' tumour suppressor protein WT1 | Q80912149 | ||
| Phase II clinical trial of Wilms tumor 1 peptide vaccination for patients with recurrent glioblastoma multiforme | Q81189851 | ||
| Descriptive epidemiology of primary brain and CNS tumors: results from the Central Brain Tumor Registry of the United States, 1990-1994 | Q30544789 | ||
| Brain tumor survival: results from the National Cancer Data Base | Q31932199 | ||
| A novel response of cancer cells to radiation involves autophagy and formation of acidic vesicles | Q32046208 | ||
| Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial | Q33453675 | ||
| The candidate Wilms' tumour gene is involved in genitourinary development | Q34189819 | ||
| Paraptosis: mediation by MAP kinases and inhibition by AIP-1/Alix | Q34326791 | ||
| The relationship between six-month progression-free survival and 12-month overall survival end points for phase II trials in patients with glioblastoma multiforme | Q35688316 | ||
| WT1 influences apoptosis through transcriptional regulation of Bcl-2 family members | Q36499914 | ||
| Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive Radiation Therapy Oncology Group (RTOG) clinical trials | Q36771292 | ||
| RNA binding by the Wilms tumor suppressor zinc finger proteins. | Q37426489 | ||
| Alternative splicing and genomic structure of the Wilms tumor gene WT1 | Q37611742 | ||
| Expression of the Wilms' tumor gene WT1 in solid tumors and its involvement in tumor cell growth | Q38326365 | ||
| A WT1 antisense oligonucleotide inhibits proliferation and induces apoptosis in myeloid leukaemia cell lines. | Q38360653 | ||
| Wilms tumor 1 expression in malignant gliomas and correlation of +KTS isoforms with p53 status | Q40077672 | ||
| Autophagy delays apoptotic death in breast cancer cells following DNA damage | Q40228732 | ||
| DNA damaging agent-induced autophagy produces a cytoprotective adenosine triphosphate surge in malignant glioma cells | Q40237176 | ||
| hnRNP-U directly interacts with WT1 and modulates WT1 transcriptional activation | Q40241092 | ||
| Autophagic cell death of malignant glioma cells induced by a conditionally replicating adenovirus | Q40284343 | ||
| Antiapoptotic function of 17AA(+)WT1 (Wilms' tumor gene) isoforms on the intrinsic apoptosis pathway | Q40308394 | ||
| WT1 induces apoptosis through transcriptional regulation of the proapoptotic Bcl-2 family member Bak. | Q40372880 | ||
| Synergistic augmentation of rapamycin-induced autophagy in malignant glioma cells by phosphatidylinositol 3-kinase/protein kinase B inhibitors. | Q40434380 | ||
| HER2/neu increases the expression of Wilms' Tumor 1 (WT1) protein to stimulate S-phase proliferation and inhibit apoptosis in breast cancer cells. | Q40464845 | ||
| Overexpression of the Wilms' tumor gene W T1 in primary astrocytic tumors | Q40500190 | ||
| Ataxia-telangiectasia mutated gene controls insulin-like growth factor I receptor gene expression in a deoxyribonucleic acid damage response pathway via mechanisms involving zinc-finger transcription factors Sp1 and WT1. | Q40519472 | ||
| Transcriptional activation of c-myc proto-oncogene by WT1 protein | Q40529835 | ||
| Pivotal role of the cell death factor BNIP3 in ceramide-induced autophagic cell death in malignant glioma cells. | Q40543801 | ||
| Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells | Q40600919 | ||
| WT1-p53 interactions in insulin-like growth factor-I receptor gene regulation | Q40688483 | ||
| Downregulation of Wilms' tumor 1 protein inhibits breast cancer proliferation | Q40716988 | ||
| Wilms' tumor suppressor gene (WT1) is expressed in primary breast tumors despite tumor-specific promoter methylation. | Q40823490 | ||
| Transcriptional regulation of insulin-like growth factor-I receptor gene expression in prostate cancer cells | Q40834085 | ||
| Internal translation initiation generates novel WT1 protein isoforms with distinct biological properties | Q40937124 | ||
| Type-1 insulin-like growth factor receptor reexpression in the malignant phenotype of SV40-T-immortalized human prostate epithelial cells enhances apoptosis | Q41095166 | ||
| The WT1 protein is a negative regulator of the normal bcl-2 allele in t(14;18) lymphomas | Q41098050 | ||
| Reexpression of the type 1 insulin-like growth factor receptor inhibits the malignant phenotype of simian virus 40 T antigen immortalized human prostate epithelial cells | Q41119806 | ||
| WT1 induces expression of insulin-like growth factor 2 in Wilms' tumor cells | Q41282537 | ||
| The WT1 gene product stabilizes p53 and inhibits p53-mediated apoptosis | Q41302327 | ||
| Expression of the wt1 Wilms' tumor gene by normal and malignant human melanocytes | Q41438299 | ||
| WT1 modulates apoptosis by transcriptionally upregulating the bcl-2 proto-oncogene | Q41786212 | ||
| The role of a low pH intracellular compartment in the processing, storage, and secretion of ACTH and endorphin | Q41911881 | ||
| The antiapoptotic gene A1/BFL1 is a WT1 target gene that mediates granulocytic differentiation and resistance to chemotherapy | Q42193837 | ||
| Cyclin E is a target of WT1 transcriptional repression | Q42817131 | ||
| A functional interaction with CBP contributes to transcriptional activation by the Wilms tumor suppressor WT1. | Q42830606 | ||
| Induction of autophagic cell death in malignant glioma cells by arsenic trioxide. | Q44427360 | ||
| Enhanced radiosensitivity of malignant glioma cells after adenoviral p53 transduction | Q44866247 | ||
| Human U251MG glioma cells expressing the membrane form of macrophage colony-stimulating factor (mM-CSF) are killed by human monocytes in vitro and are rejected within immunodeficient mice via paraptosis that is associated with increased expression o | Q46039988 | ||
| Radiation-induced autophagy is associated with LC3 and its inhibition sensitizes malignant glioma cells. | Q46421665 | ||
| Overexpression of the Wilms' tumor gene WT1 in pancreatic ductal adenocarcinoma | Q47221022 | ||
| Inhibition of tumorigenesis and induction of apoptosis in human tumor cells by the stable expression of a myristylated COOH terminus of the insulin-like growth factor I receptor | Q47988156 | ||
| Frequent co-alterations of TP53, p16/CDKN2A, p14ARF, PTEN tumor suppressor genes in human glioma cell lines | Q48154511 | ||
| Oncogenic Ras triggers cell suicide through the activation of a caspase-independent cell death program in human cancer cells | Q48211866 | ||
| The expression of the Wilms' tumour gene, WT1, in the developing mammalian embryo. | Q48369257 | ||
| Living T9 glioma cells expressing membrane macrophage colony-stimulating factor produce immediate tumor destruction by polymorphonuclear leukocytes and macrophages via a "paraptosis"-induced pathway that promotes systemic immunity against intracrani | Q48527887 | ||
| P433 | issue | 1 | |
| P921 | main subject | glioblastoma | Q282142 |
| P304 | page(s) | 87-102 | |
| P577 | publication date | 2010-09-04 | |
| P1433 | published in | Journal of Neuro-Oncology | Q15752119 |
| P1476 | title | Wilms' tumor 1 silencing decreases the viability and chemoresistance of glioblastoma cells in vitro: a potential role for IGF-1R de-repression | |
| P478 | volume | 103 |
| Q52644558 | An Interplay between Senescence, Apoptosis and Autophagy in Glioblastoma Multiforme-Role in Pathogenesis and Therapeutic Perspective. |
| Q38791893 | Combination Therapy with AKT3 and PI3KCA siRNA Enhances the Antitumor Effect of Temozolomide and Carmustine in T98G Glioblastoma Multiforme Cells. |
| Q47095382 | Function of insulin-like growth factor 1 receptor in cancer resistance to chemotherapy |
| Q35606589 | Insulin-like growth factor (IGF) signaling in tumorigenesis and the development of cancer drug resistance |
| Q52846347 | Phase I/II trial of combination of temozolomide chemotherapy and immunotherapy with fusions of dendritic and glioma cells in patients with glioblastoma. |
| Q99610842 | Ribosomal protein QM/RPL10 positively regulates defence and protein translation mechanisms during nonhost disease resistance |
| Q39849637 | Synthesis and in vitro evaluation of [18F]BMS-754807: a potential PET ligand for IGF-1R. |
| Q24633750 | Targeting the insulin growth factor receptor 1 |
| Q35556180 | The transcription factors Ik-1 and MZF1 downregulate IGF-IR expression in NPM-ALK⁺ T-cell lymphoma |
| Q50971977 | Turning back the Wheel: Inducing Mesenchymal to Epithelial Transition via Wilms Tumor 1 Knockdown in Human Mesothelioma Cell Lines to Influence Proliferation, Invasiveness, and Chemotaxis. |
| Q37582083 | WT1 shRNA delivery using transferrin-conjugated PEG liposomes in an in vivo model of melanoma |
| Q35489149 | Wilms' tumor gene 1 (WT1) silencing inhibits proliferation of malignant peripheral nerve sheath tumor sNF96.2 cell line |
Search more.